ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000254484.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.029910465	Resistant
ENSG00000254484.1	ABT-263 (navitoclax)	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.035681719	Sensitive